Duncan Williams Asset Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Duncan Williams Asset Management, LLC
- $254 Billion
- Q4 2024
A detailed history of Duncan Williams Asset Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Duncan Williams Asset Management, LLC holds 21,125 shares of APLS stock, worth $580,092. This represents 0.27% of its overall portfolio holdings.
Number of Shares
21,125
Previous 21,125
-0.0%
Holding current value
$580,092
Previous $609 Million
10.64%
% of portfolio
0.27%
Previous 0.34%
Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
304Shares Held
110MCall Options Held
3.88MPut Options Held
1.17M-
Avoro Capital Advisors LLC New York, NY12.2MShares$336 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$327 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$324 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$276 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$159 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.02B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...